###begin article-title 0
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
Two novel FBN1 mutations associated with ectopia lentis and marfanoid habitus in two Chinese families
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
To identify the molecular defects in the fibrillin-1 gene (FBN1) in two Chinese families with ectopia lentis (EL) and marfanoid habitus.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
Five patients and eight non-carriers in the two families underwent complete physical, ophthalmic, and cardiovascular examinations. Genomic DNA was extracted from leukocytes of venous blood of these individuals in the families as well as 100 healthy normal controls. Polymerase chain reaction (PCR) amplification and direct sequencing of all 65 coding exons of FBN1 were analyzed. The functional consequences of the mutations were analyzed with various genomic resources.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
Two novel mutations of FBN1 were identified in our study. One is a splice defect in intron 17 (IVS 17-1G>T) adjacent to exon 18. The other is c.6182G>T in exon 50, which results in the substitution of cysteine by phenylalanine at codon 2,061 (p. C2061F). We provided strong evidences that the splice mutation would potentially lead to the skipping of exons after intron 17 and that the missense mutation at codon 2,061 (p. C2061F) would destroy a disulfide bond.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
We detected two novel mutations in FBN1. Our results expand the mutation spectrum of FBN1 and help in the study of the molecular pathogenesis of Marfan syndrome and Marfan-related disorders.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Ectopia lentis (EL; OMIM ) is an inherited connective disorder characterized by lens dislocation, often connected with stretched or discontinuous zonular filaments [1]. In most cases, EL occurs as one symptom of Marfan syndrome (MFS; OMIM ), a genetic autosomal dominant disorder that is characterized by manifestations mainly involving the cardiovascular, skeletal, and ocular systems [2]. According to the Ghent nosology, a clinical diagnosis of MFS requires the involvement of all three systems with two major diagnostic manifestations [3]. Other disorders such as isolated EL or predominant EL with some skeletal features belong to Marfan-related disorders.
###end p 12
###begin p 13
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 770 771 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
Both Marfan syndrome and Marfan-related disorders mainly result from mutations in the fibrillin-1 gene (FBN1) [4]. FBN1 encodes a 320 kDa glycoprotein consisting of 2,871 amino acids and is located on chromosome 15q21. FBN1 is mainly composed of three types of repeated modules. The first one is the epidermal growth factor (EGF)-like module, which includes six cysteine residues. There are 47 such modules, and most of them are calcium binding (cb) EGF-like modules. The second type is called transforming growth factor beta1-binding (or TB) protein-like module (TGF beta1-BP-like module, or 8-Cys/TB), which is found seven times in FBN1. This module contains eight cysteine residues that form four disulfide bonds. The last one is a hybrid module, which occurs twice [5].
###end p 13
###begin p 14
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
In this study, we analyzed two Chinese families with EL and marfanoid habitus and detected two novel heterozygous mutations in FBN1 . In each family, the mutation found cosegregated in the patients and was not observed in any of the healthy family members.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and clinical data
###end title 16
###begin p 17
###xml 18 26 <span type="species:ncbi:9606">patients</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
###xml 480 492 <span type="species:ncbi:9606">participants</span>
In our study, the patients from two Chinese families with ectopia lentis and marfanoid habitus were from the Heilongjiang province in northeastern China. Two patients and six non-carrier relatives in Family 1, three patients and two non-carrier relatives in Family 2, and 100 healthy normal controls were recruited for this study. The study was approved by the Institutional Review Board of Harbin Medical University (Harbin, China). After obtaining informed consent from all the participants, thorough physical, ophthalmic, and cardiovascular examinations were performed.
###end p 17
###begin title 18
Genomic DNA preparation
###end title 18
###begin p 19
Blood specimens (5 ml) were collected in EDTA, and genomic DNA was extracted by the TIANamp Blood DNA Kit (Tiangen Biltech Co. Ltd, Beijing, China).
###end p 19
###begin title 20
Mutation screening
###end title 20
###begin p 21
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 261 268 261 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
All coding exons of FBN1 were amplified by polymerase chain reaction (PCR) using a set of 59 pairs of primers. The primers for exons 4, 5, 7, 11, 15, 22, 23, 31, 41, 44, 45, 51, and 52 were from those described by Li and coworkers [6]. The others are listed in Table 1. The PCR products were subsequently purified with a TIANgel Midi Purification Kit (Tiangen Biltech Co. Ltd) and sequenced with an ABI BigDye Terminator Cycle Sequencing kit v3.1 (ABI Applied Biosystems, Foster City, CA).
###end p 21
###begin title 22
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
Primers used for FBN1 amplification.
###end title 22
###begin p 23
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
Summary of the primers used for the amplification of FBN1 exons. Sequences are given in the 5'-->3'direction.
###end p 23
###begin title 24
Information theory mutational analysis
###end title 24
###begin p 25
###xml 120 121 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 460 461 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 462 463 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 482 484 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
The potential results of the G-->T transversion were estimated using information theory as described in the literature [7]. Briefly, potential splice sites were identified by the splice mutation analysis system based on information theory. Thus, the score of the site containing a mutant nucleotide would be significantly changed compared with that of the wild-type splice site. The analysis had been previously used for the interpretation of other mutations [8,9]. We used walker [10] visualization maps to present the predicted changes in binding sites.
###end p 25
###begin title 26
Structure analysis
###end title 26
###begin p 27
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
The protein structure file, 1apj, downloaded from the Protein data bank () database, demonstrates the solution structure of the transforming growth factor beta binding (TB) protein-like domain 6 of fibrillin (residues 2054-2125) [11]. This structure was displayed with the  viewer to show the missense mutation at codon 2061.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Clinical findings
###end title 29
###begin p 30
###xml 39 48 39 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 50 59 50 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 108 115 108 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 764 772 <span type="species:ncbi:9606">patients</span>
In the two families, all the patients (Figure 1A, Figure 2A) in our study showed similar clinical symptoms (Table 2). Bilateral lens dislocation was discovered in the five patients, and none of them displayed any abnormalities in the cardiovascular system by echocardiogram. However, in Family 2, individual I:2 died of congenital heart disease at the age of 30 years old with big hands according to the description of her daughter (II:2), and her granddaughter (III:1) also died of congenital heart disease only four days after birth. It was not clear whether they had any other abnormalities such as EL because they were deceased several years ago and no related medical records were available. As for the skeletal system, arachnodactyly was present in the five patients.
###end p 30
###begin title 31
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Clinical details of the five patients from the two families.
###end title 31
###begin p 32
Affected family members had bilateral ectopia lentis, and arachnodactyly. Abnormalities in the cardiovascular system were absent. Abbreviations: M: male; F: female; AS/H: arm span/height ratio; +: present, -: absent.
###end p 32
###begin title 33
Mutation analysis
###end title 33
###begin p 34
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 118 127 118 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 231 240 231 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 371 380 371 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 382 391 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
After direct sequencing of FBN1 in the five patients, a splice defect in intron 17 (IVS 17-1G>T) adjacent to exon 18 (Figure 1B) and a missense mutation involving the substitution of cysteine by phenylalanine in exon 50 (p.C2061F; Figure 2B) were discovered in Family 1 and Family 2, respectively. Neither of the two mutations was detected in the healthy family members (Figure 1C, Figure 2C) or any of the 100 unrelated control subjects.
###end p 34
###begin p 35
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 321 322 321 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 504 505 504 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 204 211 <span type="species:ncbi:9606">patient</span>
A novel FBN1 splice mutation in intron 17. A: The pedigree of Family 1 is shown. Squares and circles indicate males and females, respectively, and the darkened symbols represent the affected members. The patient above the arrow is the proband. An asterisk indicates the subject underwent clinical and molecular analyses. B: The partial nucleotide sequence of FBN1 in an affected member is shown. A heterozygous change G>T (indicated by the arrow) was identified at the boundary of intron 17 and exon 18. C: The corresponding normal sequence in an unaffected family member is displayed by an arrow.
###end p 35
###begin p 36
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 228 229 228 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 384 385 384 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
A novel FBN1 missense mutation in exon 50. A: The pedigree of Family 2 is shown. Slashed symbols denote that the subject is deceased. Symbols with a question mark in the center indicate that the member is not diagnosed clearly. B: A heterozygous G>T transversion (indicated by the arrow) resulted in the substitution of cysteine-2061 by phenylalanine (C2061F) in an affected subject. C: The corresponding normal sequence in an unaffected family member is shown by an arrow.
###end p 36
###begin title 37
Potential functional consequences of the two mutations
###end title 37
###begin p 38
###xml 113 122 113 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 256 265 256 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 351 360 351 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A</xref>
###xml 531 540 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
###xml 543 545 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
The IVS 17-1G>T mutation located at a highly conserved splice site of intron 17, which has canonical GT/AG ends (Figure 3A). Information theory analysis revealed that the information contents (Ri) value decreased from 9.2 bits to 0.5 bits by the mutation (Figure 3B). The cysteine residue at position 2,061 was also conserved among mammalian species (Figure 4A). Structure analysis of the transforming growth factor beta (TGF-beta)-binding protein-like domain revealed that C2061 and C2083 formed one of the four disulfide bonds. (Figure 4B) [11].
###end p 38
###begin p 39
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 430 431 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Analysis of the splice mutaion in intron 17. A: The alignment of the FBN1 sequence with the corresponding segments in diverse species is displayed. The nucleotide G is conserved in FBN1 proteins from several species. The sequence was selected by . Note that FBN1 is located at the minus strand, and the nucleotide sequence of this genomic region is represented by the plus strand. The 'Mammal Cons' is a conservation measurement. B: The walker diagram of 3' (acceptor) splice site in intron 17 and its adjacent sequence is shown. The wild-type sequence is at the top. Bases in splice sites are shown in the corresponding walker diagram. The arrow points to the mutant sequence with the G to T base change and shows the change from a positive contribution by the G to a near zero contribution of the T.
###end p 39
###begin p 40
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 247 248 247 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 346 351 <span type="species:ncbi:9606">human</span>
Analysis of the missense mutation in exon 50. A: The alignment of the FBN1 sequence with the corresponding segments in diverse species is shown. The cysteine is conserved in FBN1 proteins from several species. The sequence was selected from the . B: Structure analysis of the transforming growth factor-binding protein-like domains (8-Cys/TB) in human FBN1. alpha-helices and beta-strands are shown with red and brown colors. The two residues (C2061 and C2083) are colored green. The disulfide bond is represented with a dotted line.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
In this study, we described two novel heterozygous mutations in FBN1 (IVS 17-1G>T and p.C2061F). Furthermore, we used various genomic resources to analyze the potential functional consequences of these two mutations.
###end p 42
###begin p 43
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
In Family 1, it was a splice mutation in position 1 of the intron 17-exon 18 boundary in the domain of cb EGF-like number 07. EGF-like domains play a major role in the pathogenesis of fibrillinopathies containing 75% of all the FBN1 mutations registered in the FBN1 Universal Mutation Database () database. Previously, Rogan et al. [12] showed that the minimum Ri value for a functional splice site was 2.4 in a study of over 100 splice sites. As for the splice mutation in our study, the Ri value decreased from 9.2 bits to 0.5 bits. The mutation of this base would be expected to disrupt the acceptor site and potentially lead to abnormal mRNA splicing and skipping of exons after intron 17. This also supports the observation that splice mutations often lead to a shortened protein, accounting for about 11%-12% of the gene lesions in FBN1 [5,13]. Interestingly, the c. 2168-1G>T splice site mutation (in IVS 17) involved the same nucleotide of the c. 2168-1G>A substitution previously described in FBN1 [14].
###end p 43
###begin p 44
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 404 406 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 762 764 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 841 843 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 820 825 <span type="species:ncbi:10090">mouse</span>
Family 2 carried a missense mutation affecting cysteine residues in exon 50 in the domain of 8-Cys/TB number 06. This supports the previous studies that mutations involving cysteine substitution are usually associated with EL [13,15,16]. Each 8-Cys/TB module contains eight highly conserved cysteine residues holding TGF-beta in an inactive complex in various tissues including the extracellular matrix [17]. Structure analysis showed C2061 and C2083 form one of the four disulfide bonds. Therefore, the substitution of cysteine by phenylalanine in this position was likely to destroy the disulfide bond and cause domain misfolding and structure instability. Recent studies demonstrated that increased TGF-beta signaling contributed to selected symptoms of MFS [18] and could cause dysregulation of cytokine function in mouse models of MFS [19]. All above show that 8-Cys/TB domains also play an important role in the pathogenesis of fibrillinopathies.
###end p 44
###begin p 45
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBN1</italic>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
Since FBN1 cDNA was cloned and the first mutations of FBN1 were identified in MFS patients in 1991 [20-22], currently more than 1,200 FBN1 mutations have been described [23]. Most of them are missense mutations, and others are nonsense mutations, splice defect, deletions, and so on. In this study, we described two novel heterozygous mutations in FBN1 in the Chinese patients with ectopic lentis and marfanoid habitus and analyzed the potential functional consequences of the two mutations. Our data further expand the mutation spectrum of FBN1 and help in the study of molecular pathogenesis of Marfan syndrome and Marfan-related disorders.
###end p 45
###begin title 46
Acknowledgments
###end title 46
###begin p 47
###xml 36 44 <span type="species:ncbi:9606">patients</span>
The authors are grateful to all the patients and their families as well as to the normal volunteers for their participation in this study.
###end p 47
###begin title 48
References
###end title 48
###begin article-title 49
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.
###end article-title 49
###begin article-title 50
Marfan syndrome: an update of genetics, medical and surgical management.
###end article-title 50
###begin article-title 51
Revised diagnostic criteria for the Marfan syndrome.
###end article-title 51
###begin article-title 52
Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.
###end article-title 52
###begin article-title 53
Marfan syndrome in the third Millennium.
###end article-title 53
###begin article-title 54
###xml 120 128 <span type="species:ncbi:9606">Patients</span>
The Roles of Two Novel FBN1 Gene Mutations in the Genotype-Phenotype Correlations of Marfan Syndrome and Ectopia Lentis Patients with Marfanoid Habitus.
###end article-title 54
###begin article-title 55
Using information content and base frequencies to distinguish mutations from genetic polymorphisms in splice junction recognition sites.
###end article-title 55
###begin article-title 56
Autosomal dominant zonular cataract with sutural opacities is associated with a splice mutation in the betaA3/A1-crystallin gene.
###end article-title 56
###begin article-title 57
Splice site contribution in alternative splicing of PLP and DM20: molecular studies in oligodendrocytes.
###end article-title 57
###begin article-title 58
Sequence walkers: a graphical method to display how binding proteins interact with DNA or RNA sequences.
###end article-title 58
###begin article-title 59
Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils.
###end article-title 59
###begin article-title 60
###xml 24 29 <span type="species:ncbi:9606">human</span>
Information analysis of human splice site mutations.
###end article-title 60
###begin article-title 61
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.
###end article-title 61
###begin article-title 62
Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice.
###end article-title 62
###begin article-title 63
Recent progress in genetics of Marfan syndrome and Marfan-associated disorders.
###end article-title 63
###begin article-title 64
Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome.
###end article-title 64
###begin article-title 65
Marfan's syndrome and related disorders-more tightly connected than we thought.
###end article-title 65
###begin article-title 66
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
###end article-title 66
###begin article-title 67
The molecular genetics of Marfan syndrome and related disorders.
###end article-title 67
###begin article-title 68
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.
###end article-title 68
###begin article-title 69
Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.
###end article-title 69
###begin article-title 70
Partial sequence of a candidate gene for the Marfan syndrome.
###end article-title 70
###begin article-title 71
###xml 27 35 <span type="species:ncbi:9606">patients</span>
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.
###end article-title 71

